Does the media refer more to AMWL or DRIO?

In the previous week, DarioHealth had 1 more articles in the media than American Well. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for American Well. American Well's average media sentiment score of 0.88 beat DarioHealth's score of 0.60 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, DRIO or OPRX?

OptimizeRx has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DarioHealth $21.00M 3.31 -$41.71M -$6.13 N/A OptimizeRx $109.43M 1.26 $5.13M $0.23 31.70

Is DRIO or OPRX more profitable?

OptimizeRx has a net margin of 4.66% compared to DarioHealth's net margin of -169.87%. OptimizeRx's return on equity of 9.44% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets DarioHealth -169.87% -54.81% -33.36% OptimizeRx 4.66% 9.44% 7.11%

Does the media favor DRIO or OPRX?

In the previous week, DarioHealth had 1 more articles in the media than OptimizeRx. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.93 beat DarioHealth's score of 0.60 indicating that OptimizeRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer DRIO or HCAT?

In the previous week, DarioHealth had 1 more articles in the media than Health Catalyst. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.91 beat DarioHealth's score of 0.60 indicating that Health Catalyst is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to DH or DRIO?

In the previous week, Definitive Healthcare and Definitive Healthcare both had 3 articles in the media. DarioHealth's average media sentiment score of 0.60 beat Definitive Healthcare's score of 0.47 indicating that DarioHealth is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DarioHealth 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, CCLD or DRIO?

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $120.50M 0.72 $10.80M $0.07 29.29 DarioHealth $21.00M 3.31 -$41.71M -$6.13 N/A

Is CCLD or DRIO more profitable?

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 6.21% 27.07% 14.56% DarioHealth -169.87% -54.81% -33.36%

DarioHealth (DRIO) Competitors

$7.08 +0.50 (+7.66%)

Closing price 09/11/2026 03:58 PM Eastern

Extended Trading

$6.72 -0.36 (-5.07%)

As of 09/11/2026 06:34 PM Eastern

Compare

DRIO vs. AMWL, OPRX, HCAT, DH, and CCLD

Should you buy DarioHealth stock or one of its competitors? DarioHealth's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), Definitive Healthcare (DH), and CareCloud (CCLD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does DarioHealth compare to American Well?

American Well (NYSE:AMWL) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

56.1% of American Well shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 12.8% of American Well shares are held by insiders. Comparatively, 3.5% of DarioHealth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

American Well has a beta of 1.71, suggesting that its stock price is 71% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.12, suggesting that its stock price is 12% more volatile than the broader market.

American Well has a net margin of -35.75% compared to DarioHealth's net margin of -169.87%. American Well's return on equity of -30.12% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
DarioHealth	-169.87%	-54.81%	-33.36%

In the previous week, DarioHealth had 1 more articles in the media than American Well. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for American Well. American Well's average media sentiment score of 0.88 beat DarioHealth's score of 0.60 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DarioHealth	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

American Well currently has a consensus price target of $9.50, suggesting a potential downside of 27.04%. DarioHealth has a consensus price target of $10.00, suggesting a potential upside of 41.16%. Given DarioHealth's stronger consensus rating and higher probable upside, analysts plainly believe DarioHealth is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

DarioHealth has lower revenue, but higher earnings than American Well. American Well is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.86	-$95.70M	-$4.77	N/A
DarioHealth	$21.00M	3.31	-$41.71M	-$6.13	N/A

Summary

American Well beats DarioHealth on 9 of the 16 factors compared between the two stocks.

How does DarioHealth compare to OptimizeRx?

DarioHealth (NASDAQ:DRIO) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

DarioHealth has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

DarioHealth currently has a consensus target price of $10.00, suggesting a potential upside of 41.16%. OptimizeRx has a consensus target price of $11.43, suggesting a potential upside of 56.77%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

33.4% of DarioHealth shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

OptimizeRx has a net margin of 4.66% compared to DarioHealth's net margin of -169.87%. OptimizeRx's return on equity of 9.44% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
OptimizeRx	4.66%	9.44%	7.11%

In the previous week, DarioHealth had 1 more articles in the media than OptimizeRx. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.93 beat DarioHealth's score of 0.60 indicating that OptimizeRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarioHealth	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OptimizeRx has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$21.00M	3.31	-$41.71M	-$6.13	N/A
OptimizeRx	$109.43M	1.26	$5.13M	$0.23	31.70

Summary

OptimizeRx beats DarioHealth on 13 of the 16 factors compared between the two stocks.

How does DarioHealth compare to Health Catalyst?

DarioHealth (NASDAQ:DRIO) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

DarioHealth currently has a consensus price target of $10.00, suggesting a potential upside of 41.16%. Health Catalyst has a consensus price target of $2.45, suggesting a potential upside of 44.12%. Given Health Catalyst's higher possible upside, analysts plainly believe Health Catalyst is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Health Catalyst	1 Sell rating(s)	7 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

In the previous week, DarioHealth had 1 more articles in the media than Health Catalyst. MarketBeat recorded 3 mentions for DarioHealth and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.91 beat DarioHealth's score of 0.60 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DarioHealth	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

DarioHealth has a beta of 1.12, suggesting that its share price is 12% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.53, suggesting that its share price is 53% more volatile than the broader market.

DarioHealth has higher earnings, but lower revenue than Health Catalyst. DarioHealth is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$21.00M	3.31	-$41.71M	-$6.13	N/A
Health Catalyst	$311.14M	0.41	-$177.97M	-$3.68	N/A

Health Catalyst has a net margin of -90.61% compared to DarioHealth's net margin of -169.87%. Health Catalyst's return on equity of -1.83% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-169.87%	-54.81%	-33.36%
Health Catalyst	-90.61%	-1.83%	-0.80%

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 3.5% of DarioHealth shares are owned by company insiders. Comparatively, 19.4% of Health Catalyst shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Health Catalyst beats DarioHealth on 12 of the 16 factors compared between the two stocks.

How does DarioHealth compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

DarioHealth has lower revenue, but higher earnings than Definitive Healthcare. DarioHealth is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$241.52M	0.46	-$138.93M	-$1.60	N/A
DarioHealth	$21.00M	3.31	-$41.71M	-$6.13	N/A

Definitive Healthcare has a net margin of -72.28% compared to DarioHealth's net margin of -169.87%. Definitive Healthcare's return on equity of 3.55% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
DarioHealth	-169.87%	-54.81%	-33.36%

Definitive Healthcare has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.12, meaning that its stock price is 12% more volatile than the broader market.

Definitive Healthcare currently has a consensus price target of $1.47, indicating a potential upside of 40.14%. DarioHealth has a consensus price target of $10.00, indicating a potential upside of 41.16%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts clearly believe DarioHealth is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by company insiders. Comparatively, 3.5% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Definitive Healthcare and Definitive Healthcare both had 3 articles in the media. DarioHealth's average media sentiment score of 0.60 beat Definitive Healthcare's score of 0.47 indicating that DarioHealth is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DarioHealth	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Definitive Healthcare beats DarioHealth on 10 of the 16 factors compared between the two stocks.

How does DarioHealth compare to CareCloud?

CareCloud (NASDAQ:CCLD) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

CareCloud currently has a consensus target price of $3.25, indicating a potential upside of 58.54%. DarioHealth has a consensus target price of $10.00, indicating a potential upside of 41.16%. Given CareCloud's stronger consensus rating and higher possible upside, equities analysts clearly believe CareCloud is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
DarioHealth	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

CareCloud has a beta of 1.5, indicating that its share price is 50% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.12, indicating that its share price is 12% more volatile than the broader market.

CareCloud has a net margin of 6.21% compared to DarioHealth's net margin of -169.87%. CareCloud's return on equity of 27.07% beat DarioHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
DarioHealth	-169.87%	-54.81%	-33.36%

CareCloud has higher revenue and earnings than DarioHealth. DarioHealth is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.72	$10.80M	$0.07	29.29
DarioHealth	$21.00M	3.31	-$41.71M	-$6.13	N/A

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 3.5% of DarioHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, DarioHealth had 2 more articles in the media than CareCloud. MarketBeat recorded 3 mentions for DarioHealth and 1 mentions for CareCloud. CareCloud's average media sentiment score of 1.87 beat DarioHealth's score of 0.60 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Very Positive
DarioHealth	Positive

Summary

CareCloud beats DarioHealth on 12 of the 16 factors compared between the two stocks.

Get DarioHealth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DRIO vs. The Competition

Export

Metric	DarioHealth	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$67.91M	$1.70B	$7.16B	$12.85B
Dividend Yield	N/A	4.70%	2.57%	11.17%
P/E Ratio	-1.16	20.05	274.94	25.36
Price / Sales	3.31	88.35	685.44	117.05
Price / Cash	N/A	31.57	76.65	51.52
Price / Book	0.70	5.96	10.33	6.20
Net Income	-$41.71M	-$18.66M	$3.50B	$358.50M
7 Day Performance	-2.15%	-1.52%	-3.32%	-2.35%
1 Month Performance	-3.36%	0.82%	-0.53%	-3.23%
1 Year Performance	-0.37%	-14.70%	23.51%	8.79%

DarioHealth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DRIO DarioHealth	4.1303 of 5 stars	$7.08 +7.7%	$10.00 +41.2%	-0.4%	$67.91M	$21.00M	N/A	200	News Coverage
AMWL American Well	2.2692 of 5 stars	$12.89 +6.8%	$9.50 -26.3%	+97.1%	$213.37M	$218.53M	N/A	1,040	News Coverage Positive News
OPRX OptimizeRx	3.6244 of 5 stars	$8.04 +2.3%	$11.43 +42.1%	-57.9%	$151.44M	$98.65M	34.96	100
HCAT Health Catalyst	3.1742 of 5 stars	$1.69 -1.2%	$2.45 +45.0%	-45.7%	$127.18M	$292.25M	N/A	1,200	Gap Down
DH Definitive Healthcare	2.9996 of 5 stars	$1.04 +15.3%	$1.47 +41.5%	-74.7%	$111.02M	$241.52M	N/A	970	Analyst Upgrade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DRIO) was last updated on 9/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DarioHealth (DRIO) Competitors

DRIO vs. AMWL, OPRX, HCAT, DH, and CCLD

How does DarioHealth compare to American Well?

Summary

How does DarioHealth compare to OptimizeRx?

Summary

How does DarioHealth compare to Health Catalyst?

Summary

How does DarioHealth compare to Definitive Healthcare?

Summary

How does DarioHealth compare to CareCloud?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO vs. The Competition

DarioHealth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DarioHealth (DRIO) Competitors

DRIO vs. AMWL, OPRX, HCAT, DH, and CCLD

How does DarioHealth compare to American Well?

Do insiders and institutionals have more ownership in AMWL or DRIO?

Which has more risk & volatility, AMWL or DRIO?

Is AMWL or DRIO more profitable?

Does the media refer more to AMWL or DRIO?

Do analysts rate AMWL or DRIO?

Which has higher earnings & valuation, AMWL or DRIO?

Summary

How does DarioHealth compare to OptimizeRx?

Which has more volatility and risk, DRIO or OPRX?

Do analysts prefer DRIO or OPRX?

Do insiders & institutionals have more ownership in DRIO or OPRX?

Is DRIO or OPRX more profitable?

Does the media favor DRIO or OPRX?

Which has higher valuation and earnings, DRIO or OPRX?

Summary

How does DarioHealth compare to Health Catalyst?

Do analysts prefer DRIO or HCAT?

Does the media prefer DRIO or HCAT?

Which has more risk & volatility, DRIO or HCAT?

Which has better valuation & earnings, DRIO or HCAT?

Is DRIO or HCAT more profitable?

Do institutionals and insiders hold more shares of DRIO or HCAT?

Summary

How does DarioHealth compare to Definitive Healthcare?

Which has better earnings & valuation, DH or DRIO?

Is DH or DRIO more profitable?

Which has more volatility & risk, DH or DRIO?

Do analysts prefer DH or DRIO?

Do insiders & institutionals have more ownership in DH or DRIO?

Does the media refer more to DH or DRIO?

Summary

How does DarioHealth compare to CareCloud?

Do analysts rate CCLD or DRIO?

Which has more risk & volatility, CCLD or DRIO?

Is CCLD or DRIO more profitable?

Which has higher valuation and earnings, CCLD or DRIO?

Do insiders and institutionals have more ownership in CCLD or DRIO?

Does the media favor CCLD or DRIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DRIO vs. The Competition

DarioHealth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools